Orionis Biosciences Stock
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
Sign up today and learn more about Orionis Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Orionis Biosciences Stock
Orionis Biosciences
Funding History
October 2015 | $4.0M |
---|---|
April 2018 | $0 |
April 2018 | $19.7M |
Management
Founder, President and CEO
Nikolai Kley
Press
uk - Mar, 4 2024
ChemDiv Marks a Milestone as Orionis Biosciences' Novel Immunotherapy Enters Phase I Clinical Trialsbusinesswire - Mar, 4 2024
Orionis Biosciences Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011 in Patients with Advanced ...finance - Mar, 4 2024
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicinesbiopharmadive - Jan, 19 2024
Genentech takes up a deal to make 'molecular glue' drugsbiopharmadive - Dec, 22 2023
Roche is stuck on molecular glue